A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors

Phase: Recruiting

Condition(s): Germ Cell Tumor

Other Study ID Number(s): AGCT1531

Who Can Take Part in This Study?

  • Low Risk Stratum: Patients must be < 50 years of age at enrollment.
  • Standard Risk 1: Patient must be < 11 years of age at enrollment.
  • Standard Risk 2: Patients must be ≥ 11 and < 25 years of age at enrollment

Principal Investigator

Mark A. Ranalli
MD

Hematology & Oncology

Discover More Research
Explore additional studies relating to germ cell cancers.